Mariano
Ponz Sarvisé
Consultor Médico
Massachusetts General Hospital
Boston, Estados UnidosMassachusetts General Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2022
-
Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor
European Journal of Cancer, Vol. 174, pp. S116